Key result
Levosimendan infusion successfully reduced cerebral vasospasm in a patient with aneurysmal subarachnoid hemorrhage, normalizing middle cerebral artery blood flow velocities and improving neurological status.
Why the study?
Does levosimendan reduce cerebral vasospasm in a patient with massive subarachnoid hemorrhage?
Case Report (n=1)
No
Does levosimendan reduce cerebral vasospasm in a patient with massive subarachnoid hemorrhage?
Answers are grounded in this paper and cite their sources.
Levosimendan may be utilized to reduce cerebral vasospasm in patients with massive subarachnoid hemorrhage.
Despite the progress in the management of cerebral arterial aneurysms, subarachnoid hemorrhage (SAH) remains the major cause of neurological disability. While SAH-related deaths usually occur as a result of brain impairment due to hemorrhage, permanent neurological deficits are caused by cerebral ischemia due to edema and spasm of cerebral arteries. Additionally, ~20%-30% of patients with SAH develop secondary cardiomyopathy; this phenomenon is known as neurogenic stress cardiomyopathy (NSC), which is associated with increased mortality and poor long-term prognosis. Levosimendan is a new inotropic drug that causes calcium sensitization of troponin C, thus increasing contraction force of myofilaments. The drug also causes opening of ATP-dependent potassium channels in vascular smooth muscles, which results in dilatation of veins and arteries, including cerebral arteries. To date, there have been several reports of levosimendan application in patients with SAH and neurogenic stress cardiomyopathy, and the effect of the drug on vasospasm has been previously advocated. This paper presents a case report of a 57-year-old patient with massive SAH, where levosimendan was used for reducing vasospasm.
No takes yet. Share an insight, caveat, or question.
Onichimowski et al. (2018) conducted a case report in Aneurysmal subarachnoid hemorrhage with cerebral vasospasm (n=1). Levosimendan was evaluated on Cerebral blood flow velocities (vasospasm resolution). Levosimendan infusion successfully reduced cerebral vasospasm in a patient with aneurysmal subarachnoid hemorrhage, normalizing middle cerebral artery blood flow velocities and improving neurological status.
Synapse has enriched 10 related papers. Consider them for comparative context: